🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Sunway Healthcare Holdings Berhad (KLSE:SUNMED)
Malaysia flag Malaysia · Delayed Price · Currency is MYR
2.080
0.00 (0.00%)
At close: Nov 20, 2026

KLSE:SUNMED Statistics

Total Valuation

KLSE:SUNMED has a market cap or net worth of MYR 23.93 billion. The enterprise value is 24.26 billion.

Market Cap23.93B
Enterprise Value 24.26B

Important Dates

The last earnings date was Thursday, November 19, 2026.

Earnings Date Nov 19, 2026
Ex-Dividend Date n/a

Share Statistics

KLSE:SUNMED has 11.51 billion shares outstanding. The number of shares has decreased by -10.53% in one year.

Current Share Class 11.51B
Shares Outstanding 11.51B
Shares Change (YoY) -10.53%
Shares Change (QoQ) +0.05%
Owned by Insiders (%) 0.11%
Owned by Institutions (%) 15.57%
Float 3.09B

Valuation Ratios

The trailing PE ratio is 75.10 and the forward PE ratio is 58.59. KLSE:SUNMED's PEG ratio is 2.48.

PE Ratio 75.10
Forward PE 58.59
PS Ratio 9.16
PB Ratio 6.93
P/TBV Ratio 7.00
P/FCF Ratio 254.49
P/OCF Ratio 49.63
PEG Ratio 2.48
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 40.70, with an EV/FCF ratio of 257.98.

EV / Earnings 76.05
EV / Sales 9.29
EV / EBITDA 40.70
EV / EBIT 64.59
EV / FCF 257.98

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.43.

Current Ratio 1.46
Quick Ratio 1.37
Debt / Equity 0.43
Debt / EBITDA 2.48
Debt / FCF 15.74
Interest Coverage 5.91

Financial Efficiency

Return on equity (ROE) is 10.87% and return on invested capital (ROIC) is 9.44%.

Return on Equity (ROE) 10.87%
Return on Assets (ROA) 6.11%
Return on Invested Capital (ROIC) 9.44%
Return on Capital Employed (ROCE) 8.46%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.50
Inventory Turnover 9.68

Taxes

In the past 12 months, KLSE:SUNMED has paid 31.83 million in taxes.

Income Tax 31.83M
Effective Tax Rate 9.07%

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 2.11
200-Day Moving Average n/a
Relative Strength Index (RSI) 45.14
Average Volume (20 Days) 7,172,420

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, KLSE:SUNMED had revenue of MYR 2.61 billion and earned 319.04 million in profits. Earnings per share was 0.03.

Revenue2.61B
Gross Profit 1.60B
Operating Income 375.62M
Pretax Income 350.87M
Net Income 319.04M
EBITDA 579.50M
EBIT 375.62M
Earnings Per Share (EPS) 0.03
Full Income Statement

Balance Sheet

The company has 1.15 billion in cash and 1.48 billion in debt, with a net cash position of -328.17 million or -0.03 per share.

Cash & Cash Equivalents 1.15B
Total Debt 1.48B
Net Cash -328.17M
Net Cash Per Share -0.03
Equity (Book Value) 3.45B
Book Value Per Share 0.30
Working Capital 589.37M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 482.25 million and capital expenditures -388.20 million, giving a free cash flow of 94.04 million.

Operating Cash Flow 482.25M
Capital Expenditures -388.20M
Depreciation & Amortization 203.87M
Net Borrowing -134.43M
Free Cash Flow 94.04M
FCF Per Share 0.01
Full Cash Flow Statement

Margins

Gross margin is 61.45%, with operating and profit margins of 14.38% and 12.21%.

Gross Margin 61.45%
Operating Margin 14.38%
Pretax Margin 13.43%
Profit Margin 12.21%
EBITDA Margin 22.19%
EBIT Margin 14.38%
FCF Margin 3.60%

Dividends & Yields

KLSE:SUNMED does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 36.51%
FCF Payout Ratio n/a
Buyback Yield 10.53%
Shareholder Yield 10.53%
Earnings Yield 1.33%
FCF Yield 0.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Analyst Forecast

The average price target for KLSE:SUNMED is 2.05, which is -1.39% lower than the current price. The consensus rating is "Hold".

Price Target 2.05
Price Target Difference -1.39%
Analyst Consensus Hold
Analyst Count 16
Revenue Growth Forecast (3Y) 18.31%
EPS Growth Forecast (3Y) 26.05%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

KLSE:SUNMED has an Altman Z-Score of 6.86 and a Piotroski F-Score of 6.

Altman Z-Score 6.86
Piotroski F-Score 6